The efficacy of intensive glucose management on hospitalized critically ill patients associated mortality rate in intensive care unit

Daru

Volumn 17, Issue 3, 2009, Pages 157-162

  Taslimi, R ^a   Azizkhani, R ^b   Talebian, M H ^a   Abtahi, H R ^a   Jalili, M ^a   Nejati, A ^a   Labbaf, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Critically ill; Intensive care unit; Intensive glucose therapy; Mortality

Indexed keywords

INSULIN; MONOCOMPONENT INSULIN;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY;

EID: 70350348909     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Van Den Berghe. G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R.. Intensive insulin therapy in the critically ill patients. N Engl J Med, 2001;345:1359-1367 (Pubitemid 34940724)
2. Takala J., Ruokonen E., Webster N.R., Nielsen M.S., Zandstra D.F.,Vundelinckx G., Hinds C.J.. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med, 1999;341:785-792 (Pubitemid 29420473)
3. Mizock B.A.. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med, 1995; 98:75-84.
4. McCowen K.C., Malhotra A., Bistrian B.R.. Stress-induced hyperglycemia. Crit Care Clin ,2001; 17:107-124
5. Capes S.E., Hunt D., Malmberg K., Gerstei H.C.. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet ,2000; 355:773-778 (Pubitemid 30128815)
6. Cely C.M., Arora p., Quartin A.A., Kett D.H., Schein R.M.H.. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest, 2004;126:879-887
7. Zochodne D.W., Bolton C.F., Wells G.A., Gilbert J.J., Hahn A.F., Brown J.D., Sibbald W.A.. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain, 1987;110:819-841
8. Leijten F.S.,de Weerd A.W.. Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg, 1994; 96:10-19 (Pubitemid 124011034)
9. Webb A.R., Shapiro M.J., Singer M., Suter P.M.. Oxford textbook of critical care. Oxford, England: Oxford University Press, 1999:490-495
10. Bolton C.F.. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med,1996; 24:1408-1416 (Pubitemid 26262418)
11. Knauss W.A.. Measuring the Glasgow Coma Scale in the intensive care unit: potentials and pitfalls Intensive Care World ,1995; 11:102-103
12. Capes S.E., Hunt D., Malmberg K., Gerstein H.C.. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet, 2000; 355:773-778 (Pubitemid 30128815)
13. Bellomo R., Chapman M., Finfe S., Hickling K., Myburgh J.. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet, 2000; 356:2139-2143
14. Lassnigg A., Donner E., Grubhofer G., Presterl E., Druml W., Hiesmayr M.. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol, 2000; 11:97-104. (Pubitemid 30020431)
15. Lewis J., Salem M.M., Chertow G.M., Weisberg L.S., McGrew F., Marbury T.C., Allgren, R.L.. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis, 2000; 36:767-774
16. Thadhani R., Pascual M., Bonventre J.V.. Acute renal failure. N Engl J Med,1996; 334:1448-1460
17. Jones R.S., Putna W., Andersen D.K., Hanks J.B., Lebovitz H.E.. Insulin's effect on bile flow and lipid excretion during euglycemia and hypoglycemia. Dig Dis Sci, 1984;29:33-39 (Pubitemid 14177231)
18. Garcia-Marin J.J., Villanueva G.R., Esteller A.. Diabetes-induced cholestasis in the rat: possible role of hyperglycemia and hypoinsulinemia. Hepatology, 1988; 8:332-340 (Pubitemid 18134263)
19. Sidenius P.. The axonopathy of diabetic neuropathy. Diabetes, 1982; 31:356-363
20. Ferrando A.A., Chinkes D.L., Wolf S.E., Matin S., Herndon D.N., Wolfe R.R.. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg, 1999;229:11-18 (Pubitemid 30190375)
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993;329:977-986
22. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998;352:837-853